Meeting: November 14-15, 2024 | In-Person
The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.
While we develop our 2024 agenda, please take a moment to review the 2023 final agenda.
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.
Very insightful conference. Time well invested. – Thierry Page, Executive VP, COO, Starpax Biopharma Inc
The best conference for Canadian content of 2022. – RPatricia Smith, Director, Regulatory Affairs, QA and PV, Otsuka Canada Pharmaceutical Inc.
Want to learn more about Canada Annual Meeting? You've come to the right site!